https://www.taxtmi.com/news?id=34027 Jubilant Biosys Innovative Research Services Pte. Limited will acquire 80% of JASMIN from Pierre Fabre, with JASMIN acquiring Pierre Fabre's R&D Centre and R&D activities at Saint Julien en Genevois, France. The transaction includes a Shareholders' Agreement and transition agreements to govern post closing operations. The acquisition secures majority control of a biologics and ADC focused R&D site, aims to integrate Pierre Fabre's scientific expertise with Jubilant's chemistry and payload capabilities, and is positioned to expand ADC/CDMO market access and cross selling opportunities in EU and US markets, subject to forward looking disclaimers. en-us Fri, 14 Feb 2025 10:16:03 +0530 Fri, 14 Feb 2025 10:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=34027 Jubilant Biosys Innovative Research Services Pte. Limited will acquire 80% of JASMIN from Pierre Fabre, with JASMIN acquiring Pierre Fabre's R&D Centre and R&D activities at Saint Julien en Genevois, France. The transaction includes a Shareholders' Agreement and transition agreements to govern post closing operations. The acquisition secures majority control of a biologics and ADC focused R&D site, aims to integrate Pierre Fabre's scientific expertise with Jubilant's chemistry and payload capabilities, and is positioned to expand ADC/CDMO market access and cross selling opportunities in EU and US markets, subject to forward looking disclaimers. News - Fri, 14 Feb 2025 10:16:03 +0530 https://www.taxtmi.com/news?id=34027